Tarsus Pharmaceuticals Inc (TARS)
EBITDA Margin
-5.82%
TTM · Period ending:
TARS EBITDA Margin
Latest reported-5.82%period ending
Latest reported-5.82%period ending
TARS TTM EBITDA Margin (-42.02% → -5.82%)
TTM ebitda margin
High-resolution chart · PNG
TARS ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -5.8178% | |
| -7.5209% | |
| -12.3928% | |
| -19.8438% | |
| -27.4613% | |
| -40.4191% | |
| -58.2007% | |
| -97.7288% | |
| -172.7937% | |
| -337.2806% | |
| -755.041% | |
| -723.5057% | |
| -701.848% | |
| -224.6859% | |
| -230.9847% | |
| -381.1997% | |
| -320.2196% | |
| -182.7008% | |
| -23.6029% | |
| -17.8871% | |
| -7.7585% | |
| -42.0166% |